The global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Growth in this market is mainly driven by rising demand for rapid diagnostics, increasing disease incidence, advancements in bacterial testing, and water testing regulations. However, a lack of reimbursement and difficulties in detection may affect market growth.
The legionnaires disease Market report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173145333
Global Water Treatment Industries Market Vendor Analysis
The key players in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).
In 2021, Thermo Fisher Scientific, Inc. (US) held the leading position in the Legionella testing market. The company has maintained a leading position in the market through its strong distribution networks across North America, Europe, and the Asia Pacific. Thermo Fisher has a strong direct and indirect distribution network across the globe. Thermo Fisher adopts organic and inorganic growth strategies.
In 2021, Merck accounted for second largest share of the Legionella testing market. Merck’s leading position in this market can be attributed to its strong global sales and distribution network. It has also increased its focus on R&D. Merck’s R&D investments and capital allocation strategies will fuel its future growth and ability to remain competitive. In addition, Merck’s strategies, which involve acquisitions, aim to strengthen its position in the market. In June 2020, the company acquired Resolution Spectra Systems S.A.S. (France).
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333
Related Reports:
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
